Education
About Us
Working with TipRanks
Follow Us
Nemaura Medical (NMRD)
:NMRD
Total Valuation
Nemaura Medical has a market cap or net worth of $4.04K. The enterprise value is ―.
Market Cap$4.04K
Enterprise Value―
Share Statistics
Nemaura Medical has 40,351,704 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding40,351,704
Owned by Insiders―
Owned by Institutions2.09%
Financial Efficiency
Nemaura Medical’s return on equity (ROE) is 1.20 and return on invested capital (ROIC) is -103.87%.
Return on Equity (ROE)1.20
Return on Assets (ROA)-0.97
Return on Invested Capital (ROIC)-103.87%
Return on Capital Employed (ROCE)1.25
Revenue Per Employee2.14K
Profits Per Employee-392.88K
Employee Count36
Asset Turnover<0.01
Inventory Turnover0.89
Valuation Ratios
The current PE Ratio of Nemaura Medical is -1.57. Nemaura Medical’s PEG ratio is ―.
PE Ratio-1.57
PS Ratio0.00
PB Ratio>-0.01
Price to Fair Value-1.88
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio―
Income Statement
In the last 12 months, Nemaura Medical had revenue of 77.04K and earned -14.14M in profits. Earnings per share was -0.57.
Revenue77.04K
Gross Profit-1.48M
Operating Income-9.60M
Pretax Income-14.14M
Net Income-14.14M
EBITDA-7.29M
Earnings Per Share (EPS)-0.57
Cash Flow
In the last 12 months, operating cash flow was -9.57M and capital expenditures -177.22K, giving a free cash flow of -9.74M billion.
Operating Cash Flow-9.57M
Free Cash Flow-9.74M
Free Cash Flow per Share-0.24
Dividends & Yields
Nemaura Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-270.74
52-Week Price Change-50.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)7.20K
Important Dates
Nemaura Medical upcoming earnings date is Nov 11, 2024, TBA Not Confirmed.
Last Earnings DateAug 12, 2024
Next Earnings DateNov 11, 2024
Ex-Dividend Date―
Financial Position
Nemaura Medical as a current ratio of 0.61, with Debt / Equity ratio of -169.54%
Current Ratio0.61
Quick Ratio0.53
Debt to Market Cap0.90
Net Debt to EBITDA-1.36
Interest Coverage Ratio-1.50
Taxes
In the past 12 months, Nemaura Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Nemaura Medical EV to EBITDA ratio is -4.42, with an EV/FCF ratio of -3.58.
EV to Sales417.83
EV to EBITDA-4.42
EV to Free Cash Flow-3.58
EV to Operating Cash Flow-3.81
Balance Sheet
Nemaura Medical has $137.42K in cash and marketable securities with $19.64M in debt, giving a net cash position of $19.51M billion.
Cash & Marketable Securities$137.42K
Total Debt$19.64M
Net Cash$19.51M
Net Cash Per Share$0.48
Tangible Book Value Per Share-$0.49
Margins
Gross margin is -1916.30%, with operating margin of -12454.23%, and net profit margin of -18358.00%.
Gross Margin-1916.30%
Operating Margin-12454.23%
Pretax Margin-18358.00%
Net Profit Margin-18358.00%
EBITDA Margin-9458.31%
EBIT Margin-10034.83%
Analyst Forecast
The average price target for Nemaura Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―